Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease

Keyphrases

• Newcastle Disease Vaccine 100%
• Hamster 100%
• COVID-19 100%
• Intranasal Vaccination 100%
• S1 Subunit 100%
• Vaccine Candidate 50%
• Recombinant Newcastle Disease Virus 50%
• Control Strategy 25%
• Immunogenicity 25%
• Mitigation Strategies 25%
• Protective Efficacy 25%
• Viral Load 25%
• Safety Efficacy 25%
• Neutralizing Antibodies 25%
• Humoral Immune Response 25%
• Long-term Control 25%
• Viral-vectored Vaccine 25%
• Resistant Variants 25%
• Novel Variants 25%
• Lung Damage 25%
• Respiratory Tract 25%
• Catastrophe 25%
• Human Trials 25%
• Short-term Solution 25%
• Coronavirus disease-19 Pandemic 25%
• Vaccine-resistant 25%
• Intranasal Administration 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• SARS Coronavirus 100%
• Newcastle Disease Virus 100%
• Viral Vector 100%
• Coronavirinae 50%
• Immunogenicity 25%
• Clinical Trial 25%
• Respiratory Tract 25%
• Neutralizing Antibody 25%
• Lung Injury 25%

Immunology and Microbiology

• Newcastle Disease Virus 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Viral Vector 100%
• Coronavirinae 66%
• Solution and Solubility 33%
• Immunogenicity 33%
• Viral Load 33%
• Neutralizing Antibody 33%
• Humoral Immunity 33%